ADD/ADHD News

WEST PALM BEACH, Fla. — Researchers have identified a positive association between multiple sclerosis and ADHD, as well as a trend toward an earlier diagnosis of MS among those with ADHD, according to a poster presented at ACTRIMS.

The American Society of Anesthesiologists released new guidance on the safe use of ketamine for nonanesthesia purposes, such as the treatment of mental health disorders, according to an organization press release.

Prefrontal transcranial direct current stimulation induced small- to medium-sized clinical effects in cognitive and clinical metrics in youths with ADHD with no serious adverse effects, according to a study published in JAMA Network Open.

Adolescents in the United States with symptoms of ADHD had a higher likelihood of using tobacco and other nicotine-based products, results from a cohort study published in JAMA Network Open showed.

The FDA approved 16 psychiatric drugs over the last decade, most of which shared similar mechanisms of action with previously developed drugs, according to data in a research latter published in JAMA Network Open.

Although stimulant dispensing rates have rebounded to — or exceeded — pre-pandemic levels among girls, the dispensing rate among adolescent boys was almost 19% lower than it was before March 2020, according to study findings.

Adults in the United Kingdom with an ADHD diagnosis appear to have shorter lifespans compared with the general population, likely due to unmet health support and treatment needs, according to a study in The British Journal of Psychiatry.

In a large network meta-analysis of pharmacological, psychological and neurostimulatory ADHD interventions, only stimulants and atomoxetine were associated with short-term reductions in core symptoms among adults.

Hundreds of millions of psychiatric disorders in the United States have been linked to childhood exposure of car exhaust from leaded gasoline, according to a recent study in the Journal of Child Psychology and Psychiatry.